ArticleJournal of the National Cancer Institute2024

Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in US breast cancer survivors.

Jacqueline B Vo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.